Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 16 Nov 2026
Standard addition

Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial.

Tirzepatide combined with healthy lifestyle changes significantly reduced BMI in adolescents with obesity, offering a new treatment option for this growing population.

This PubMed record examines Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial. It reports CONCLUSIONS AND RELEVANCE: In adolescents with obesity or overweight with obesity-related complications, tirzepatide, in addition to healthy lifestyle intervention, led to significant reductions in percent change in BMI compared with placebo at 72 weeks.

What the study was

Study design
Phase 3 randomized controlled trial
Population
Human participants
Category
Public Health
Maturity
Validated
Journal
JAMA

Why it surfaced

Phase 3 randomized controlled trial; conservative rapid-triage score based on PubMed title, publication type, and abstract.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.